S 
STERIS plc STE · USD
Health Care · Health Care Equipment & Supplies · US listing · 🇺🇸 United States
S&P 500
256.94
+1.84%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$5.94bn
FY2017FY2026
Net income
$785.1m
FY2017FY2026
Free cash flow
$972.4m
FY2017FY2026
Shareholders' equity
$7.18bn
FY2017FY2026
Income statement
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.94bn | $5.46bn | $5.14bn | $4.54bn | $4.22bn | $3.11bn | $3.03bn | $2.78bn | $2.62bn | $2.61bn |
| Gross profit | $2.63bn | $2.40bn | $2.22bn | $1.98bn | $1.88bn | $1.34bn | $1.32bn | $1.17bn | $1.09bn | $1.03bn |
| Research and development | $112.9m | $107.6m | $103.7m | $98.5m | $86.7m | $66.3m | $65.5m | $63.0m | $60.8m | $59.4m |
| Operating income | $1.10bn | $866.6m | $836.1m | $791.1m | $477.8m | $548.4m | $537.0m | $411.0m | $399.9m | $226.2m |
| Net income | $785.1m | $614.6m | $378.2m | $107.0m | $243.9m | $397.4m | $407.7m | $304.1m | $290.9m | $110.0m |
| Diluted earnings per share | 8.02 | 6.22 | 3.82 | 1.08 | 2.43 | 3.94 | 4.74 | 3.55 | 3.40 | 1.28 |
Balance sheet
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $10.74bn | $10.15bn | $11.06bn | $10.82bn | $11.42bn | $6.57bn | $5.43bn | $5.07bn | $5.20bn | $4.92bn |
| Cash and short-term investments | $439.6m | $171.7m | $207.0m | $208.4m | $348.3m | $220.5m | $319.6m | $220.6m | $201.5m | $282.9m |
| Total liabilities | $3.54bn | $3.53bn | $4.75bn | $4.73bn | $4.88bn | $2.68bn | $2.02bn | $1.89bn | $1.98bn | $2.11bn |
| Debt | $1.97bn | $2.04bn | $3.21bn | $3.08bn | $3.09bn | $1.65bn | $1.15bn | $1.18bn | $1.32bn | $1.48bn |
| Shareholders' equity | $7.18bn | $6.60bn | $6.30bn | $6.09bn | $6.53bn | $3.89bn | $3.41bn | $3.19bn | $3.22bn | $2.81bn |
| Shares outstanding | 98m | 99m | 99m | 99m | 100m | 101m | 86m | 86m | 85m | 86m |
Cash flow
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $1.34bn | $1.15bn | $973.3m | $756.9m | $684.8m | $689.6m | $590.6m | $539.5m | $457.6m | $424.1m |
| Capital spending | −$369.0m | −$370.1m | −$360.3m | −$362.0m | −$287.6m | −$239.3m | −$214.5m | −$189.7m | −$165.5m | −$172.9m |
| Free cash flow | $972.4m | $778.0m | $612.9m | $395.0m | $397.2m | $450.4m | $376.0m | $349.8m | $292.2m | $251.2m |
| Dividends paid | −$241.8m | −$219.9m | −$200.6m | −$183.5m | −$163.2m | −$133.8m | −$123.0m | −$112.5m | −$102.9m | −$93.2m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49bn | $1.59bn | $1.50bn | $1.46bn | $1.39bn | $1.48bn | $1.37bn | $1.33bn |
| Gross profit | $684.2m | $697.1m | $655.5m | $645.9m | $628.0m | $641.2m | $610.3m | $578.8m |
| Operating income | $285.8m | $316.8m | $271.0m | $268.0m | $246.0m | $216.2m | $245.3m | $219.7m |
| Net income | $200.1m | $220.3m | $192.8m | $191.9m | $177.4m | $145.7m | $173.5m | $150.0m |
| Diluted earnings per share | 2.04 | 2.25 | 1.95 | 1.94 | 1.80 | 1.47 | 1.75 | 1.52 |
| Cash from operations | $367.0m | $335.0m | $298.0m | $287.0m | $420.0m | $260.0m | $332.0m | $250.0m |
| Capital spending | −$87.0m | −$90.0m | −$98.0m | −$86.0m | −$93.0m | −$70.0m | −$89.0m | −$101.0m |
| Free cash flow | $280.0m | $245.0m | $200.0m | $201.0m | $327.0m | $190.0m | $243.0m | $149.0m |
| Total assets | $10.74bn | $10.74bn | $10.59bn | $10.41bn | $10.40bn | $10.15bn | $10.01bn | $10.24bn |
| Cash and short-term investments | $482.3m | $439.6m | $423.7m | $319.2m | $279.7m | $171.7m | $155.2m | $172.2m |
| Debt | $1.93bn | $1.97bn | $1.93bn | $1.93bn | $1.94bn | $2.08bn | $2.20bn | $2.27bn |
| Shareholders' equity | $7.21bn | $7.18bn | $7.17bn | $7.01bn | $6.96bn | $6.60bn | $6.42bn | $6.59bn |
Financial ratios
Data as of 24 Sept 2026
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 44.2% | 44.0% | 43.2% | 43.7% | 44.6% | 43.2% |
| Operating margin | 18.6% | 15.9% | 16.3% | 17.4% | 11.3% | 17.6% |
| Net margin | 13.2% | 11.3% | 7.4% | 2.4% | 5.8% | 12.8% |
| Return on equity | 10.9% | 9.3% | 6.0% | 1.8% | 3.7% | 10.2% |
| Return on assets | 7.3% | 6.1% | 3.4% | 1.0% | 2.1% | 6.0% |
| Free cash flow yield | 8.3% | 7.3% | 6.4% | 5.4% | 4.6% | 4.4% |
| Revenue growth | 8.7% | 6.2% | 13.3% | 7.4% | 35.9% | 2.5% |
| Earnings growth | 27.7% | 62.5% | 253.4% | -56.1% | -38.6% | -2.5% |
| Current ratio | 2.09x | 1.96x | 3.08x | 2.33x | 2.04x | 2.10x |
| Debt to equity | 0.27x | 0.31x | 0.51x | 0.51x | 0.48x | 0.43x |
| Equity ratio | 66.9% | 65.1% | 57.0% | 56.2% | 57.2% | 59.2% |
| Interest coverage | 18.15x | 10.05x | 5.79x | 7.14x | 5.34x | 14.75x |
| R&D as a share of sales | 1.9% | 2.0% | 2.0% | 2.2% | 2.1% | 2.1% |
| Buybacks as a share of market value | 0.9% | 0.1% | 0.4% | 0.8% | 0.7% | -17.2% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 9.4% | 13.8% | 10.2% |
| Operating income | 11.7% | 15.0% | 17.9% |
| Net income | 94.3% | 14.6% | 21.6% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 44.1% | 43.8% | 43.9% | 43.1% |
| Operating margin | 17.3% | 17.1% | 16.3% | 15.4% |
| Net margin | 12.3% | 8.9% | 8.9% | 9.0% |
Valuation history
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 30.9 | 40.8 | 53.8 | 204.1 | 75.8 | 61.8 | 40.0 | 42.9 | 31.4 | 68.2 |
| Price to sales | 4.1 | 4.6 | 4.0 | 4.8 | 4.4 | 7.9 | 5.4 | 4.7 | 3.5 | 2.9 |
Market value over time
31 Oct 2016 to 23 Sept 2026, in USD
$5.75bn$20.56bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 22% | -5% | 21% | -20% | 23% | 23% | 43% | 18% | 29% | -7% |
Dividends and splits
Per share, in the currency the company pays
Paid for 21 years. Last went ex-dividend on 4 Sept 2026.
| FY2027 | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 1.32 | 2.46 | 2.23 | 2.03 | 1.84 | 1.69 | 1.57 | 1.45 |
- 1-to-1 reverse split · 3 Nov 2015
- 2-for-1 split · 25 Aug 1998
- 2-for-1 split · 25 Aug 1995
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.